Epidemiologic characteristics of hypertension in the civilians of Kosovo after the war

Central European Journal of Public Health

Volumn 13, Issue 2, 2005, Pages 61-65

  Markoglou, N Ch ^a   Hatzitolios, A I ^b,c   Savopoulos, Ch G ^b   Ziakas, A G ^b   Koutsopoulos, D ^a   Metallidis, S ^b  

^a Greek Force of Kosovo ^*  (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Epidemiology; Hypertension; Kosovo; Non steroid anti inflammatory drugs; Steroids; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLONIDINE; CORTISONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA; MOXONIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADRENERGIC SYSTEM; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; DRUG COMBINATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PROTEINURIA; RHEUMATIC DISEASE; SEX DIFFERENCE; STEROID THERAPY; STRESS; WAR; YUGOSLAVIA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CORTISONE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SYMPATHETIC NERVOUS SYSTEM; WAR; YUGOSLAVIA;

EID: 20444450570     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Boitsov SA, Karpenko MA, Kuchmin AN, Pestova LV, Belokon GV: Clinical manifestation of hypertension in citizens of siege Leningrad (1941-1944). Retrospective analysis of archive materials. Tel Arkh. 2000; 72: 54-8.
2. Ramirez MO, Pino CT, Lee AJ: Paraguayan National Blood Pressure Study: prevalence of hypertension in the general population. J Hum Hypertens. 1995; 9: 891-7.
3. Aguero Torres H, Fratiglioni L, Lindberg J, Winbland B: Hypertension in the elderly population: prevalence data from an urban area in Sweden. Aging Milano. 1994; 6: 249-55.
4. Heitzler VN, Bergovec M, Prpic H, et al: Hyperdynamic β-adrenergic syndrome among Croatian soldiers engaged in battle. Wien Med Wchschr. 1993; 143(18): 479-81.
5. Wyss JM: The role of the sympathetic nervous system in hypertension. Curr Opin Nephrol Hypertens. 1993; 2: 265-73.
6. Brunjes S: Catecholamine metabolism in essential hypertension. N Engl J Med. 1964; 271: 120-4.
7. Spiegel SB, Salama P: War and mortality in Kosovo, 1998-99: an epidemiological testimony. Lancet. 2000; 355: 2204-9.
8. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A: The influence of menopause on blood pressure. J Hum Hypertens. 1989; 3(6): 427-33.
9. Mancia G, Sega R, Milesi C, et al: Blood-pressure control in the hypertensive population. Lancet. 1997; 349: 454-457.
10. Strasser T: Assessing the quality and effects of hypertension control in populations. J Hum Hypertens. 1996; 10 (suppl 3): S1-S8.
11. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD: Prevalence, awareness, treatment and control of hypertension in Greece: the Didima study. Am J Hypertens. 1999; 12: 959-65.
12. Pope JE. Anderson JJ, Felson DT: A metaanalysis of the effects of NSAIDs on B.P. Arch Intern Med. 1993; 153: 477-84.
13. De Leeuw PW: Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs. 1996; 51: 179-87.
14. The sixth report of the joint National Committee on Detection. Evaluation and treatment of high blood pressure. (JNC VI). Arch Intern Med. 1997; 157(21): 2413-16.
15. Matějka J, Bobák M, Vojtišek P, Franc P: Control of hypertension in the Czech part of the Pardubice-Augsburg Study. Vnitr̀ Lěk. 1998; 44(11): 633-6 (in Czech).
16. Blendon RJ, Scheck AC, Donelan K, et al: How white and African Americans view their health and social problems. JAMA. 1995; 273: 341-46.
17. Ooi WL, Budner NS, Cohen H, et al: Impact of race on treatment response on cardiovascular disease among hypertensives. Hypertension. 1989; 14: 227-34.
18. Monane M, Bohn RL, Gurwitz JH: Compliance with antihypertensive therapy among elderly medicaid enrolles: the roles of age gender and race. Am J Publ Health. 1996; 86: 1804-1808.
19. Brunner HR, Menard J, Waeber B, et al: Treating the individual hypertensive patient. Considerations on dose, sequential monotherapy and drug combinations. J Hypertens. 1990; 8: 3-11.
20. th Ed. 1998: 229-49.
21. Morgan TO, Anderson A, Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000; 13(11): 1161-70.
22. Baisac J, Henrich WL: Nephrotoxicity of non-steroidal anti-inflammatory drugs. Miner Electrolyte Metab. 1994; 20: 187-92.
23. Whelton A, Fort JG, Puma JA et al: Cyclooxygenase-2 specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther. 2001; 8(2): 85-95.
24. Whelton A: Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors. Am J Med. 2001; 19(110)Suppl 3A: 33S-42S.
25. Johnson AG: NSAIDs and increased blood pressure. What is the clinical significance? Drug Saf. 1997; 17(5): 277-89.
26. Lindhohn LH, Hansson L, Ekbom T et al: Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. Hypertension-2 Study Group. J Hypertens. 2000; 18(11): 1671-5.
27. Poulter NR, Zographos D, Mattin R, Sever PS, Thorn SM: Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practises. Blood Press. 1996; 5(4): 209-15.
28. Ruilope LM, Rodicio JL: Clinical relevance of proteinuria and microalbuminuria. Curr Opin Nephrol Hypertens. 1993; 2: 962-7.
29. Sagar S, Rosangluaia, Kumari S, Sharma BK: Proteinuria in essential hypertension. Indian J Med Res. 1991; 94: 50-4.
30. Gosling P, Beevers DG: Urinary albumin excretion and blood pressure in the general population. Clin Sci. 1989; 76: 39-42.
31. Kordonouri O, Dracou C, Papadellis F, Touroutsika P: Glomerular microproteinuria in children treated with non-steroidal anti-inflammatory drugs for juvenile chronic arthritis. Clin Exp Rheumatol. 1994; 12(5): 567-71.
32. Kuhlmann MK, Kohler H: The RENAAL Study. Effect of losartan on diabetic nephropathy. Internist. 2002; 43(5): 675-7.
33. Mogensen CE: The reno-protective role of AT(l)-receptor blockers. J Hum Hypertens. 2002; 16 (Suppl3): S52-8.